Back to results
US 8,802,663 B2Granted
Pyrazole oxadiazole derivatives as S1P1 agonists
AssigneeMerck Serono SA
InventorsAnna Quattropani, Charles Baker-Glenn, Wesley Blackaby, Chris Knight
Life of this patent
Estimating the term…
Abstract
The present invention relates to pyrazole oxadiazoles derivatives of Formula (I), and their use for treating multiple sclerosis and other diseases, wherein R1, R2 and R3 are as defined in the description.
Claims8
A compound of formula (I):
- wherein
- R1 is
- R2 is selected from the following groups:
- R3 is Ar2, Het1, Cyc, A, CH3, or S—(C1-C6-alkyl);
- A is a branched or linear alkyl having 2 to 12 C-atoms, wherein one or more H-atoms may be replaced by Hal, OR4, CN, CO2R4, or CF3;
- cycloalkyl having 3 to 7 ring carbon atoms;
- Ar2, or N(R4)2 and wherein one or more non-adjacent CH2-groups may be replaced by O, NR4, —CO—, NR4CO2—, —CO2—, —NR4CONR4—, —CH═CH—, —C≡C—, or A is cycloalkyl or cycloalkylalkylene having 3-7 ring C atoms, or A is Het2;
- Z is a branched or linear alkyl having 2 to 12 C-atoms, wherein one or more H-atoms are replaced by Hal, OR4, CN, CO2R4, CF3, cycloalkyl having 3 to 7 ring carbon atoms, Ar2, N(R4)2and/or wherein one or more CH2-groups are replaced by O, NR4, S, —CO—, NR4CO2—, —NR4CONR4—, —CH═CH—, —C≡C—, or Z is cycloalkyl or cycloalkylalkylene having 3-7 ring C atoms;
- Hal is F, Cl, Br or I;
- Ar2 is a monocyclic or bicyclic, unsaturated or aromatic carbocyclic ring having 6 to 14 carbon atoms which may be unsubstituted, monosubstituted, disubstituted or trisubstituted by substituents selected from Z, F, Br, I, —OR4, —(CH2)OR4, —(CH2)N(R4)2, Perfluoro-alkoxy, —SO2R4, —CN, —NO2, —N(R4)2, —CO(NR4)2, (NR4)COR4, —CO2R4, —COR4, —SO2N(R4)2, —SO2alkyl, NR4SO2(C1-C6)alkyl, —(CH2)nHet1, —OHet1, or CF3;
- Het1 is a monocyclic saturated, unsaturated or aromatic heterocyclic ring or a bicyclic, saturated, or unsaturated heterocyclic ring having 1 to 4 N, O and/or S atoms which may be unsubstituted, monosubstituted, disubstituted or trisubstituted by substituents selected from A, Hal, —OR4, —(CH2)OR4, Perfluoro-alkyl, Perfluoro-alkoxy, —SO2(R4)2, CN, NO2, —N(R4)2, —CO(NR4)2, (NR4)COR4, —CO2R4, —COR4, —SO2N(R4)2, —SO2alkyl, NR4SO2alkyl, NR4SO2alkyl, or C1-C6 alkyl;
- Cyc is a saturated or unsaturated carbocyclic ring containing 3 to 7 carbon atoms which may be substituted by Hal, A, (C1-C6)alkyl, [C(R4)2]n-cycloalkyl, OR4, CF3, OCF3, N(R4)2, NR4CON(R4)2, NO2, CN, —[C(R4)2]n—COOR4, —[C(R4)2]n—CON(R4)2, NR4COA, NR4SO2A, COR4, SO2N(R4)2, SOA, and/or SO2A;
- R4 is H, A, Cyc or (C1-C6)alkyl;
- n is 0, 1, 2, 3 or 4;
- and pharmaceutically acceptable solvates, tautomers, salts and stereo-isomers thereof.
12 more elements
A process for the preparation of a compound of formula (I):
- wherein
- R1 is
- R2 is selected from the following groups:
- R3 is Ar2, Het1, Cyc, A, CH3, or S—(C1-C6-alkyl);
- A is a branched or linear alkyl having 2 to 12 C-atoms, wherein one or more H-atoms may be replaced by Hal, OR4, CN, CO2R4, or CF3;
- cycloalkyl having 3 to 7 ring carbon atoms;
- Ar2, or N(R4)2 and wherein one or more non-adjacent CH2-groups may be replaced by O, NR4, —CO—, NR4CO2—, —CO2—, —NR4CONR4—, —CH═CH—, —C≡C—, or A is cycloalkyl or cycloalkylalkylene having 3-7 ring C atoms, or A is Het2;
- Z is a branched or linear alkyl having 2 to 12 C-atoms, wherein one or more H-atoms are replaced by Hal, OR4, CN, CO2R4, CF3, cycloalkyl having 3 to 7 ring carbon atoms, Ar2, N(R4)2 and/or wherein one or more CH2-groups are replaced by O, NR4, S, —CO—, NR4CO2—, —NR4CONR4—, —CH═CH—, —C≡O—, or Z is cycloalkyl or cycloalkylalkylene having 3-7 ring C atoms;
- Hal is F, CI, Br or I;
- Ar2 is a monocyclic or bicyclic, unsaturated or aromatic carbocyclic ring having 6 to 14 carbon atoms which may be unsubstituted, monosubstituted, disubstituted or trisubstituted by substituents selected from Z, F, Br, I, —OR4, —(CH2)OR4, —(CH2)N(R4)2, Perfluoro-alkoxy, —SO2R4, —CN, —NO2, —N(R4)2, —CO(NR4)2, (NR4)COR4, —CO2R4, —COR4, —SO2N(R4)2, —SO2alkyl, NR4SO2(C1-C6)alkyl, —(CH2)nHet1, —OHet1, or CF3;
- Het1 is a monocyclic saturated, unsaturated or aromatic heterocyclic ring or a bicyclic, saturated, or unsaturated heterocyclic ring having 1 to 4 N, O and/or S atoms which may be unsubstituted, monosubstituted, disubstituted or trisubstituted by substituents selected from A, Hal, —OR4, —(CH2)OR4, Perfluoro-alkyl, Perfluoro-alkoxy, —SO2(R4)2, CN, NO2, —N(R4)2, —CO(NR4)2, (NR4)COR4, —CO2R4, —COR4, —SO2N(R4)2, —SO2alkyl, NR4SO2alkyl, NR4SO2alkyl, or C1-C6 alkyl;
- Cyc is a saturated or unsaturated carbocyclic ring containing 3 to 7 carbon atoms which may be substituted by Hal, A, (C1-C6)alkyl, —[C(R4)2]n-cycloalkyl, OR4, CF3, OCF3, N(R4)2, NR4CON(R4)2, NO2, CN, —[C(R4)2]n—COOR4, —[C(R4)2]n,—CON(R4)2, NR4COA, NR4SO2A, COR4, SO2N(R4)2, SOA, and/or SO2A;
- R4 is H, A, Cyc or (C1-C6)alkyl;
- and
- n is 0, 1, 2, 3 or 4;
- said method comprising the step of reacting a compound of formula (V)
- with a compound of formula (IV)
- or (VI)
- wherein R1, R2, R3 and R4 are as defined above.
16 more elements
A process for the preparation of compounds of formula (I)
- wherein
- R1 is
- R2 is selected from the following groups:
- R3 is Ar2, Het1, Cyc, A, CH3, or S—(C1-C6-alkyl);
- A is a branched or linear alkyl having 2 to 12 C-atoms, wherein one or more H-atoms may be replaced by Hal, OR4, CN, CO2R4, or CF3;
- cycloalkyl having 3 to 7 ring carbon atoms;
- Ar2, or N(R4)2 and wherein one or more non-adjacent CH2-groups may be replaced by O, NR4, —CO—, NR4CO2—, —CO2—, —NR4CONR4—, —CH═CH—, —C≡O—, or A is cycloalkyl or cycloalkylalkylene having 3-7 ring C atoms, or A is Het2;
- Z is a branched or linear alkyl having 2 to 12 C-atoms, wherein one or more H-atoms are replaced by Hal, OR4, CN, CO2R4, CF3, cycloalkyl having 3 to 7 ring carbon atoms, Ar2, N(R4)2 and/or wherein one or more CH2-groups are replaced by O, NR4, S, —CO—, NR4CO2—, —NR4CONR4—, —CH═CH—, —C≡O—, or Z is cycloalkyl or cycloalkylalkylene having 3-7 ring C atoms;
- Hal is F, CI, Br or I;
- Ar2 is a monocyclic or bicyclic, unsaturated or aromatic carbocyclic ring having 6 to 14 carbon atoms which may be unsubstituted, monosubstituted, disubstituted or trisubstituted by substituents selected from Z, F, Br, I, —OR4,—(CH2)OR4, —(CH2)N(R4)2, Perfluoro-alkoxy, —SO2R4, —CN, —NO2, —N(R4)2, —CO(NR4)2, (NR4)COR4, —CO2R4, —COR4, —SO2N(R4)2, —SO2alkyl, NR4SO2(C1-C6)alkyl, —(CH2)nHet1, —OHet1, or CF3;
- Het1 is a monocyclic saturated, unsaturated or aromatic heterocyclic ring or a bicyclic, saturated, or unsaturated heterocyclic ring having 1 to 4 N, O and/or S atoms which may be unsubstituted, monosubstituted, disubstituted or trisubstituted by substituents selected from A, Hal, —OR4, —(CH2)OR4, Perfluoro-alkyl, Perfluoro-alkoxy, —SO2(R4)2, CN, NO2, —N(R4)2, —CO(NR4)2, (NR4)COR4, —CO2R4, —COR4, —SO2N(R4)2, —SO2alkyl, NR4SO2alkyl, NR4SO2alkyl, or C1-C6 alkyl;
- Cyc is a saturated or unsaturated carbocyclic ring containing 3 to 7 carbon atoms which may be substituted by Hal, A, (C1-C6)alkyl, —[C(R4)2]n-cycloalkyl, OR4, CF3, OCF3, N(R4)2, NR4CON(R4)2, NO2, CN, —[C(R4)2]n—COOR4, —[C(R4)2]n—CON(R4)2, NR4COA, NR4SO2A, COR4, SO2N(R4)2, SOA, and/or SO2A;
- R4 is H, A, Cyc or (C1-C6)alkyl;
- and
- n is 0, 1, 2, 3 or 4;
- said method comprising the step of reacting a compound of formula (XI)
- with a compound of Formula (XII)
- wherein R1, R2, R3 and R4 are as defined above.
15 more elements
Dependencies are inferred from the claim text.